Sol-Gel Technologies (SLGL) Non Operating Income (2018 - 2026)
Sol-Gel Technologies (SLGL) reported Non Operating Income of $481,000 for Q2 2026, up 26.6% from $380,000 a year earlier.
Sol-Gel Technologies (SLGL) Non Operating Income (2018 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Sol-Gel Technologies' Non Operating Income came in at $1.12 million, up 34.7% year-over-year; for FY2025, it was $1.41 million, down 1.6% from FY2024.
- Non Operating Income has a five-year compound annual growth rate of 8.4% (FY2020 to FY2025).
- By year, Non Operating Income came in at $1.43 million in FY2024 (-30.6%), $2.07 million in FY2023 (+56.5%), $1.32 million in FY2022 (+414.0%) and $257,000 in FY2021 (-72.7%).
- The Q2 2026 figure ranks as the highest quarterly Non Operating Income since Q4 2023.
- Year over year, Non Operating Income gained in three of the last six quarters, with an average decline of 0.2%.
- The high point for year-over-year Non Operating Income in five years was Q4 2022 (growth of 475.3%); the low point was Q3 2021 (a decline of 90.6%).
- Per Business Quant data, the three quarters before Q2 2026 came in at -$128,000 (Q1 2026), $424,000 (Q4 2025) and $346,000 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | - |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | - |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | -73.00 Mn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 387.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | - |
| 10 | Sol-Gel Technologies | 206.96 Mn | 61.37 Mn | - | 481,000.00 |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 481,000.00 |
| Mar 31, 2026 | -128,000.00 |
| Dec 31, 2025 | 424,000.00 |
| Sep 30, 2025 | 346,000.00 |
| Jun 30, 2025 | 380,000.00 |
| Mar 31, 2025 | -261,000.00 |
| Dec 31, 2024 | 253,000.00 |
| Sep 30, 2024 | 462,000.00 |
| Jun 30, 2024 | 352,000.00 |
| Mar 31, 2024 | -368,000.00 |
| Dec 31, 2023 | 571,000.00 |
| Sep 30, 2023 | 596,000.00 |
| Jun 30, 2023 | 557,000.00 |
| Mar 31, 2023 | -342,000.00 |
| Dec 31, 2022 | 420,000.00 |
| Sep 30, 2022 | 218,000.00 |
| Jun 30, 2022 | -329,000.00 |
| Mar 31, 2022 | -353,000.00 |
| Dec 31, 2021 | 73,000.00 |
| Sep 30, 2021 | 14,000.00 |
Sol-Gel Technologies Non Operating Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-operating-income&ticker=SLGL&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-operating-income", "ticker": "SLGL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=non-operating-income&ticker=SLGL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();